KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Return on Equity (2016 - 2026)

Amgen has reported Return on Equity over the past 18 years, most recently at 0.01% for Q1 2026.

  • For Q1 2026, Return on Equity changed 0.0% year-over-year to 0.01%; the TTM value through Mar 2026 reached 0.01%, changed 0.0%, while the annual FY2025 figure was 0.01%, 0.0% changed from the prior year.
  • Return on Equity for Q1 2026 was 0.01% at Amgen, up from 0.01% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.04% in Q2 2022 and troughed at 0.01% in Q2 2024.
  • A 5-year average of 0.01% and a median of 0.01% in 2025 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: increased 3bps in 2022 and later fell -3bps in 2023.
  • Year by year, Return on Equity stood at 0.02% in 2022, then crashed by -46bps to 0.01% in 2023, then tumbled by -37bps to 0.01% in 2024, then skyrocketed by 38bps to 0.01% in 2025, then grew by 4bps to 0.01% in 2026.
  • Business Quant data shows Return on Equity for AMGN at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.